Enanta Pharmaceuticals
ENTA
ENTA
98 hedge funds and large institutions have $419M invested in Enanta Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 81 → 98 (+17)
15% more call options, than puts
Call options by funds: $1.35M | Put options by funds: $1.17M
Holders
98
Holding in Top 10
4
Calls
$1.35M
Puts
$1.17M
Top Buyers
| 1 | +$12.6M | |
| 2 | +$11.8M | |
| 3 | +$9.65M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.55M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$4.91M |
Top Sellers
| 1 | -$20M | |
| 2 | -$2.36M | |
| 3 | -$2.09M | |
| 4 |
Bank of New York Mellon
New York
|
-$1.38M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.29M |